TCF7L2 and Response to Diabetes Treatment
Author Information
Author(s): Andreas Holstein, Michael Hahn, Antje Körner, Michael Stumvoll, Peter Kovacs
Primary Institution: University of Leipzig
Hypothesis
Do patients with diabetes risk alleles at rs7903146 have an altered response to sulfonylureas?
Conclusion
Patients with diabetes risk alleles in TCF7L2 have a different response to sulfonylureas, leading to earlier treatment failure.
Supporting Evidence
- The TCF7L2 genotype was the only predictor of sulfonylurea treatment failure.
- The rs7903146 T allele was more frequent in patients who failed to respond to sulfonylureas.
- Patients with the T allele had a higher risk of treatment failure.
Takeaway
Some people with diabetes have a gene that makes their medicine not work as well, so they might need to try different treatments.
Methodology
Logistic regression was used to analyze the relationship between TCF7L2 genotype and sulfonylurea treatment failure.
Limitations
The study had a low sample size, which may limit the statistical power of the findings.
Participant Demographics
Patients with type 2 diabetes treated with sulfonylureas, average age around 78 years, mixed gender.
Statistical Information
P-Value
0.046
Confidence Interval
1.01-2.45
Statistical Significance
p=0.046
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website